FDA Approves AstraZeneca's Imfinzi For Limited-Stage Small Cell Lung Cancer
Clever Culture Systems Wins Second Major Order From AstraZeneca for APAS Independence Instruments
AstraZeneca Orders 4 More Microbiological Scanners From Clever Culture Systems for $3M
Top Gap Ups and Downs on Wednesday: CRM, NOW, AZN and More
Express News | FDA Approves Durvalumab For Limited-Stage Small Cell Lung Cancer; Recommended Durvalumab Dose Is 1,500 MG Every 4 Weeks For Patients With A Body Weight Of ≥30 KG; Approved Astrazeneca's Imfinzi For Adults With LS-SCLC Whose Disease Has Not Progressed...
AstraZeneca Appoints Iskra Reic as Executive Vice President, International
loading...
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
